model-based selection of breast cancer patients for proton ......apr 29, 2019 · erik korevaar,...
TRANSCRIPT
![Page 1: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/1.jpg)
1
Model-based selection of breast cancer
patients for proton therapy
Anne Crijns, MD, PhD
Department of Radiation Oncology
University Medical Center Groningen
Groningen
The Netherlands
![Page 2: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/2.jpg)
2
Disclosures
COI status Names of companies / organizations
① Post of executive / consultant No
② Stocks No
③ Patent royalties No
④ Stage moneys No
⑤ Manuscript fees No
⑥ Grant / Research funding YES Department of Radiation Oncology has research collaborations
with IBA, RaySearch, Siemens and Mirada
⑦ Other rewards No
![Page 3: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/3.jpg)
3
CASE 1
• BC patient of 61 years
- No cardiac risk factors
- Breast conserving surgery of the left
breast + sentinel node: pT1cN1mi(sn)M0
invasive carcinoma
- Parasternal uptake on scintigraphy
- Treatment
- Locoregional RT including internal
mammary chain
Photons: MHD 6.39
![Page 4: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/4.jpg)
4
CASE 2
• BC patient of 40 years
- Cardiac risk factor: BMI >30
- Breast conserving surgery of the left
breast + SN: pT1bN0(i+)M0 invasive
carcinoma
- Treatment
- Local RT
Photons: MHD 2.56
![Page 5: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/5.jpg)
5
CASE 3
• BC patient of 63 years
- Cardiac risk factors: BMI >30, diabetes,
hypertension, hypercholesterolemia
- Breast conserving surgery of the left
breast + SN: pT1cN1ma(sn)M0 invasive
carcinoma
- Treatment
- Locoregional RT
Photons: MHD 1.61
![Page 6: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/6.jpg)
6
• Proton therapy is an expensive treatment
• Limited available in the Netherlands
Model-based selection of breast cancer patients for
proton therapy based on model for acute coronary
events (ACE)
Indication for proton therapy?
Source: National Indication Protocol Proton Therapy Breast Cancer (The Netherlands, 2018)
![Page 7: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/7.jpg)
7
Model for acute coronary events
• Relative risk increases linearly by 7.4% / Gy MHD
• No dose threshold
• < 5 years after RT
Darby, N Engl J Med 2013
How to translate the relative risk
of 7.4 % / Gy into an excess risk
for an individual patient?
![Page 8: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/8.jpg)
8
Risk on ACE Excess risk in relation to baseline risk Dutch population
0%
5%
10%
15%
20%
25%
30%
35%
40%
0 1 2 3 4 5 6 7 8 9 10
Ris
k o
n A
CE
Mean heart dose (Gy)
Male with risk factors
Male without risk factors
Female with risk factors
Female without risk factors
![Page 9: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/9.jpg)
9
0%
5%
10%
15%
20%
25%
30%
35%
40%
0 1 2 3 4 5 6 7 8 9 10
Ris
k o
n A
CE
Mean heart dose (Gy)
Male with risk factors
Male without risk factors
Female with risk factors
Female without risk factors
Baseline risk
21%
5%
If dose = 10 Gy
If dose = 10 Gy
Excess risk: 3.8%
Excess risk: 15.6%
Risk on ACE Excess risk in relation to baseline risk Dutch population
![Page 10: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/10.jpg)
10
Ph
oto
ns
P
roto
ns
∆NTCP ≥2%
according
criteria
National
Indication
Protocol ?
Photons no
Protons yes
How does model-based selection work?
Plan comparison
MHD
PHOTON
plan
MHD
PROTON
plan
NTCP-model Selection
Source: National Indication Protocol Proton Therapy Breast Cancer (The Netherlands, 2018)
![Page 11: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/11.jpg)
11
CASE 1 pT1cN1mi(sn)M0 invasive carcinoma
Photons Protons
![Page 12: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/12.jpg)
12
CASE 2
pT1bN0(i+)M0 invasive carcinoma
Photons Protons
![Page 13: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/13.jpg)
13
CASE 3
pT1cN1ma(sn)M0 invasive carcinoma
Photons
![Page 14: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/14.jpg)
14
• Model for ACE will be further optimized
• Models for other late (cardiac) complications
- Heart failure
- Pneumonitis
- Secondary tumors
Better selection of BC patients for proton therapy
Model-based selection protons
![Page 15: Model-based selection of breast cancer patients for proton ......Apr 29, 2019 · Erik Korevaar, ir, PhD Jan Hietkamp Patrick Kalk Julius Center Utrecht Ewoud Schuit, PhD National](https://reader033.vdocuments.us/reader033/viewer/2022051808/600b576781c962701c6cd540/html5/thumbnails/15.jpg)
UMC Groningen Protonen Therapie Centrum (GPTC) Acknowledgements
Department of Radiation Oncology
Prof. Hans Langendijk, MD, PhD
John Maduro, MD, PhD
Marleen Woltman, MD
Dianne Busz, MD
Max Beijert, MD
Olga Chouvalova, MD
Gertjan Stiekema, PA
Estelle Batin, ir, PhD
Erik Korevaar, ir, PhD
Jan Hietkamp
Patrick Kalk
Julius Center Utrecht Ewoud Schuit, PhD
National Platform Radiotherapy
Breast Cancer
National Platform Proton Therapy